James Molloy
Stock Analyst at Alliance Global Partners
(0.50)
# 3,885
Out of 4,829 analysts
33
Total ratings
23.53%
Success rate
-44.03%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.30 | +1,074.70% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $0.54 | +1,476.99% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $20.80 | +68.27% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $0.93 | +1,517.08% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $6.97 | +186.94% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $490 | $4.04 | +12,028.71% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $18.83 | +5,741.74% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.53 | +229.88% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $3.02 | +231.13% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $1.10 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $1.02 | +1,272.55% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.12 | +2,578.57% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.04 | +618.53% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.27 | +279.51% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.56 | +412.82% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $2.79 | +150.90% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.26 | +6,248.70% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.82 | +1,851.93% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.36 | +3,788.89% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.80 | +1,775.00% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $6.23 | +134,731.46% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $1.67 | +8,882.04% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.28 | +73,142.19% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.35 | +966.10% | 1 | Oct 4, 2021 |
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.30
Upside: +1,074.70%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.54
Upside: +1,476.99%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $20.80
Upside: +68.27%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.93
Upside: +1,517.08%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $6.97
Upside: +186.94%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $4.04
Upside: +12,028.71%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $18.83
Upside: +5,741.74%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.53
Upside: +229.88%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $3.02
Upside: +231.13%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $1.10
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $1.02
Upside: +1,272.55%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.12
Upside: +2,578.57%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.04
Upside: +618.53%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.27
Upside: +279.51%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.56
Upside: +412.82%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $2.79
Upside: +150.90%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.26
Upside: +6,248.70%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.82
Upside: +1,851.93%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.36
Upside: +3,788.89%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.80
Upside: +1,775.00%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $6.23
Upside: +134,731.46%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $1.67
Upside: +8,882.04%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.28
Upside: +73,142.19%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $2.35
Upside: +966.10%